DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Life ScienceLife Science
  4. /LNPLNP
  5. /LNP Raw MaterialLNP Raw Material
  6. /ALC-0315ALC-0315
Chemical structure of CAS 2036272-55-4

ALC-0315

CAS No.2036272-55-4
MDL No.MFCD33402175
MFC48H95NO5
MW766.30
InChI KeyQGWBEETXHOVFQS-UHFFFAOYSA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.2036272-55-4
Product NameALC-0315
Heavy Atom Count54Rotatable Bond Count44
Atom Stereo Count2Bond Stereo Count0
HBA6HBD1
TPSA76.070 ŲCharge0
Exact Mass765.72103Complexity718.21
pKa11.433XLogP13.942

Related Articles

Studies related to this compound and its mechanism of action

Facile alkylation of methionine by benzyl bromide and demonstration of fumarase inactivation accompanied by alkylation of a methionine residue.

The Journal of biological chemistry • Vol. 251, Issue 18 • 1976
PMID: 9397

Documentation

Similar Products

  • [7-[4-(Dipropylamino)butyl]-13-(2-hexyloctanoyloxy)-7-hydroxytridecyl] 2-hexyloctanoate

    CAS No.2766493-12-1

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact